Focus: Metaphore Biotechnologies is a pre-revenue biotech company developing therapeutics based on biomimicry principles, with a pipeline spanning neurology, infectious diseases, gastroenterology, oncology, and ophthalmology. The company is actively hiring (75 open roles) and based in Boston.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Hot — 72 jobs added in 30d
Net +44 (72 new, 28 removed). Aggressive expansion phase.
Metaphore is a high-risk, early-stage discovery platform bet best suited for scientists seeking cutting-edge biomimicry research with moderate job security concerns.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Metaphore Biotechnologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Metaphore Biotechnologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company